(1/4) INVITATION: Biobanks & Genomics in LMICs – Emerging Opportunities for Research & Health Economics Webinar & Panel Discussion

🗓️ Wed 28 May
⏰ 8-9am UTC / 9-10am BST / 4-5pm CST
📍 Online, download the calendar invite here: healtheconomics.org/event/bioban...

(1/4) 2-WEEKS TO GO: Showcasing #ECR Research in #HealthEconomics – #BRCAScreening Webinar

🗓️ Thurs 9 Apr
⏰ 7-8am UTC / 8-9am BST / 3-4pm CST / 5-6pm AEST
📍 Online, download the calendar invite here: healtheconomics.org/event/showca...

(1/4) INVITATION: Showcasing #ECR Research in #HealthEconomics – #BRCAScreening Webinar
🗓️ Thurs 9 Apr
⏰ 7-8am UTC / 8-9am BST / 3-4pm CST / 5-6pm AEST
📍 Online, download the calendar invite here: healtheconomics.org/event/showca...

📣 Please complete a short survey nominating important or impactful 2025 papers for #healtheconomics in #genomics & #precisionmedicine. Top papers will be submitted for the #IHEA #ArrowAward.

🗓️ Deadline: 12 Jan 2026
🔗 q.surveys.unimelb.edu.au/jfe/form/SV_...

🌟 Review highlights challenges &opportunities in using #genomics in #medicine. The authors call for agile, real-world data–driven evaluation strategies and a whole-system approach to integrate genomics equitably and sustainably in #healthcare. @hadleyssmith.bsky.social

Read Here: buff.ly/An6N5wn

www.nature.com/articles/s41...

🔥🔥🔥 Is genomics value for money??? 🧬💰

👉 How do we define it?
👉 Measure it?
👉 And deliver it?

rdcu.be/eR243

@iliasgoranitis.bsky.social @stephaniebest.bsky.social @hadleyssmith.bsky.social @rich-genomics.bsky.social @jbuchanan-ox.bsky.social @rdexeter.bsky.social

HERC Webinar: Hadley Stevens Smith - From Crib to Clinic: The Economic and Ethical Trade-offs of Genomic Sequencing in Newborn Screening and Diagnosis Online surveys is a powerful, easy to use tool for creating online surveys. Run by Jisc, online surveys is used by over 300 different organisations in the UK...

UPCOMING WEBINAR

From Crib to Clinic: The Economic and Ethical Trade-offs of Genomic Sequencing in Newborn Screening and Diagnosis

Dr @hadleyssmith.bsky.social

Tues 21 Oct 10:30 h UK BST onsite/online

Free event registration app.onlinesurveys.jisc.ac.uk/s/oxford/her...

@oxpop.bsky.social

(1/4) TWO-WEEKS: Webinar exploring distributional cost-effectiveness analysis (#DCEA) in #genomicmedicine

🗓️ Date & time: 6-7pm Wed 8 Oct EDT / 10-11pm Wed 8 Oct UTC / 9-10am Thurs 9 Oct AEDT
📍 Online, download the calendar invitation (+Zoom link) here: healtheconomics.org/event/advanc...

The recording from this event is now available! #mendelianrandomisation #mendelianrandomization #genomics #healtheconomics #costeffectiveness #CEA

www.youtube.com/watch?v=ui0n...

#Duchennemusculardystrophy affects ~2 in 10,000 boys, yet #diagnosis in the U.S. still comes later, around age 5. #Newbornscreening can help catch #DMD earlier when #care & emerging #therapies can make the biggest difference.

#RareDisease #Genomics #pediatric

@hadleyssmith.bsky.social

#Metachromatic #leukodystrophy (#MLD) is rare—1 in 100,000 births—but devastating if missed. A new two-tier #newbornscreen can catch it early, enabling #genetherapy that improves #survival & motor #outcomes. #pediatric #genomics #rarediseases

@hadleyssmith.bsky.social

Read More: buff.ly/qx2xQcx

(1/4) INVITATION: Applying #MendelianRandomization in #HealthEconomics - Bridging #Genomics & #CostEffectiveness

🗓️ Tues 16 Sept
⏰8-9 AM UTC / 9-10 AM BST / 6-7 PM AEST
📍Online, download the calendar invite here: healtheconomics.org/event/applyi...

Looking forward to participating in this webinar to discuss our work on distributional cost-effectiveness analysis in genomic medicine, recently published in Value in Health www.sciencedirect.com/science/arti...

Facing the Next Generation of US Newborn Screening This Viewpoint discusses the critical role of the Advisory Committee on Heritable Disorders in Newborns and Children and the importance of continued national guidance to the future of US newborn scree...

U.S. newborn screening is entering a new era, marked by the promise of genomic technologies and absence of a key national guidance committee.

@mattmotta.bsky.social and I discuss recent events in the newborn screening policy space in a new JAMA Pediatrics Viewpoint. jamanetwork.com/journals/jam...

Interested in economic impacts of genomic medicine? Our iHEA Special Interest Group on economics of genomics would love to hear from you via the survey below!

When families bridge the research-clinical divide: An exploration of values regarding cascade screening in genomic research Genetic results are important for both patients and their biological relatives. However, cascade screening (CS) uptake is low, especially when testing occurs through research programs and not clinical...

Do investigators have obligations to the relatives of genomic research participants who have a significant result? We explored cascade screening across the clinical-research divide in focus groups with clinicians, patient representatives, and ELSI scholars. www.gimopen.org/article/S294...

New paper! @hadleyssmith.bsky.social and team's paper An end to #genetic exceptionalism: reframing the #ethics of #genomicsequencing for rapid #neonatal #diagnosis is featured in Semin Perinatol!

Read More Here: buff.ly/Zh7Js2G

Glad to see ACMG stepping up to support the continuation of evidence-based reviews to inform national newborn screening recommendations after termination of the federal advisory committee

(1/6) Calling all Early Career Researchers & Health Economists interested in Genomics & Precision Medicine!

The #IHEA Econ-Omics SIG invites you to our ECR Journal Club webinar:

🗓️ Tuesday, 15 July
⏰ 8-10am UTC | 9-11am BST | 6-8pm AEST
🔗 Register: healtheconomics.org/event/early-...

It was wonderful to have @sallysansom.bsky.social visit with us at @cherpdpm.bsky.social & the Precision Medicine Translational Research (PROMoTeR) Center and learn more about her work to advance rigor of patient-centered outcome measurement in #genomics and #raredisease!

Considering using distributional cost-effectiveness analysis to evaluate a genomic medicine intervention? We specify a commonly used conceptual framework, the staircase of inequality, for the genomic medicine context. Read more here: urldefense.com/v3/__https:/...

We are excited to share that CHeRP fellow Ramesh Lamsal, PhD will be presenting at our next CHeRP Seminar on 5/19 at 1pm! He will present Beyond the #Patient: #Methods for Including #Family Spillovers in #Pediatric and #Maternal Cost-Utility #Analyses!

#Conference #ISPORAnnual #HEOR #Genomics #rarediseases #patient

Join us on May 2 for an introduction to two types of NIH grants for research training and career development. We will cover the basics of the grant application process and explore the purpose of the K99/R00 and K01 awards.

Register: ow.ly/4t4r50VCEhu

New Publication! CHeRP faculty Hadley S. Smith and peers' paper #Rare #disease narratives on #socialmedia: A content #analysis is featured in Genetics in Medicine Open!

Read More Here: buff.ly/2HZPBWN

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @hadleyssmith.bsky.social @sallysansom.bsky.social

Looking forward to joining this panel at @asnpls.bsky.social to discuss findings from clinical and survey research studies in pediatric genomic medicine.

(1/4) Attention Early Career Researchers (ECRs)! We are still collecting expressions of interest for our ECR ‘Preprint Club’ series for 2025. #IHEA #healtheconomics #genomics #precisionmedicine

Eric Green is out as head of National Human Genome Research Institute The longtime director of the National Human Genome Research Institute is stepping down, as the larger NIH braces for more changes.

The longtime director of the National Human Genome Research Institute is stepping down, as the larger NIH braces for more changes.

Grateful for the community and continuous career development opportunities that @smdm.bsky.social provides